Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

31.62
-0.4700-1.46%
Post-market: 31.620.00000.00%19:51 EDT
Volume:1.71M
Turnover:54.73M
Market Cap:3.97B
PE:-22.10
High:33.00
Open:32.09
Low:31.37
Close:32.09
52wk High:41.14
52wk Low:10.83
Shares:125.46M
Float Shares:109.51M
Volume Ratio:1.28
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:16.59
PE(LYR):-20.66

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 11

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

TIPRANKS
·
May 10

Stock Track | Amylyx Pharmaceuticals Plummets 8.16% Intraday on Wider-Than-Expected Q1 Loss

Stock Track
·
May 08

Amylyx Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Amylyx Pharmaceuticals Q1 net loss widens more than expected on higher R&D costs

Reuters
·
May 07

Earnings Flash (AMLX) Amylyx Posts Q1 Loss $0.37 a Share, vs. FactSet Est of $0.35 Loss

MT Newswires Live
·
May 07

Amylyx Pharma Q1 EPS $(0.37), Inline, Cash, Cash Equivalents, And Short-Term Investments Were $279.8M, With Expected Cash Runway into 2028

Benzinga Earnings
·
May 07

Amylyx Q1 net loss widens to $41.3 million

Reuters
·
May 07

BRIEF-Amylyx Pharmaceuticals Q1 EPS USD -0.37 Vs. IBES Estimate USD -0.33

Reuters
·
May 07

Amylyx Pharmaceuticals Inc - Cash Runway Expected to Fund Operations Into 2028

THOMSON REUTERS
·
May 07

Press Release: Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Amylyx management participates in Bank of America Health Care Conference fireside chat

Reuters
·
May 06

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults With Post-Bariatric Hypoglycemia

THOMSON REUTERS
·
May 05

Amylyx Pharmaceuticals Inc - Avexitide Phase 3 Lucidity Trial Topline Data Readout Anticipated in Q3 2026

THOMSON REUTERS
·
May 05

Amylyx Pharmaceuticals Inc - Commercial Launch of Avexitide Anticipated in 2027 IF Approved

THOMSON REUTERS
·
May 05

Amylyx Pharmaceuticals to report first-quarter financial results, host conference call

Reuters
·
Apr 30

Amylyx Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 23

Amylyx to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 08

A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone

Simply Wall St.
·
Apr 07